Nothing Special   »   [go: up one dir, main page]

Bayer et al., 2021 - Google Patents

Model transferability and reduced experimental burden in cell culture process development facilitated by hybrid modeling and intensified design of experiments

Bayer et al., 2021

View HTML
Document ID
3081125721984924213
Author
Bayer B
Duerkop M
Striedner G
Sissolak B
Publication year
Publication venue
Frontiers in Bioengineering and Biotechnology

External Links

Snippet

Reliable process development is accompanied by intense experimental effort. The utilization of an intensified design of experiments (iDoE)(intra-experimental critical process parameter (CPP) shifts combined) with hybrid modeling potentially reduces process development …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48Automatic or computerized control

Similar Documents

Publication Publication Date Title
Bayer et al. Model transferability and reduced experimental burden in cell culture process development facilitated by hybrid modeling and intensified design of experiments
Haringa et al. From industrial fermentor to CFD-guided downscaling: what have we learned?
von Stosch et al. Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study
Huang et al. Quantitative intracellular flux modeling and applications in biotherapeutic development and production using CHO cell cultures
CN115151869A (en) Computer-implemented method, program, and hybrid system for observing cell metabolic state
US10872680B2 (en) Computer-implemented method for creating a fermentation model
US20230323275A1 (en) Monitoring and control of bioprocesses
CN111615674B (en) Scaling tool
US20240304284A1 (en) Monitoring, simulation and control of bioprocesses
Shah et al. Multi‐rate observer design and optimal control to maximize productivity of an industry‐scale fermentation process
Spann et al. A compartment model for risk-based monitoring of lactic acid bacteria cultivations
Smiatek et al. Generic and specific recurrent neural network models: Applications for large and small scale biopharmaceutical upstream processes
Hagrot et al. Novel column generation-based optimization approach for poly-pathway kinetic model applied to CHO cell culture
Hartmann et al. Digital models in biotechnology: towards multi-scale integration and implementation
Suarez-Zuluaga et al. Accelerating bioprocess development by analysis of all available data: A USP case study
Bogaerts et al. From MFA to FBA: Defining linear constraints accounting for overflow metabolism in a macroscopic FBA-based dynamical model of cell cultures in bioreactor
Pinto et al. Hybrid deep modeling of a CHO-K1 fed-batch process: combining first-principles with deep neural networks
Abbate et al. Inference of dynamic macroscopic models of cell metabolism based on elementary flux modes analysis
Hernández Rodríguez et al. Design, optimization, and adaptive control of cell culture seed trains
Hebing et al. Efficient generation of models of fed-batch fermentations for process design and control
Komives et al. Bioprocessing technology for production of biopharmaceuticals and bioproducts
Narayanan et al. Consistent value creation from bioprocess data with customized algorithms: Opportunities beyond multivariate analysis
Vorlet et al. Digitalization in Processes: FH-HES Universities of Applied Sciences
Agarwal et al. Hybrid modeling for in silico optimization of a dynamic perfusion cell culture process
Mueller et al. Self-driving development of perfusion processes for monoclonal antibody production